Trimetazidine dihydrochloride
Trimetazidine dihydrochloride can improve myocardial glucose utilization by inhibiting fatty acid metabolism. Trimetazidine is the first cytoprotective anti-ischemic agent, also used as a vasodilator in ischemic heart disease or angina.
| Catalog Number | T0988 |
| Alternative Name(s) | Yoshimilon , Kyurinett , Vastarel F |
| Research Area | Metabolism|||Autophagy |
| Molecular Formula | C14H24Cl2N2O3 |
| CAS# | 13171-25-0 |
| SMILES | Cl.Cl.COC1=C(OC)C(OC)=C(CN2CCNCC2)C=C1 |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Trimetazidine dihydrochloride |
| Additional Information | https://www.targetmol.com/datasheet/T0988 |
